Royal Bank of Canada’s Trinity Biotech TRIB Stock Holding History

Royal Bank of Canada’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-33	Closed	-$1K	–	7702
2025 Q4	$1K	Buy	+33	New	+$973	﹤0.01%	7052
2021 Q1	–	Sell	-3	Closed	-$1K	–	7705
2020 Q4	$1K	Sell	3 -4	-57%	-$1.99K	﹤0.01%	6971
2020 Q3	$2K	Hold	7	–	–	﹤0.01%	6340
2020 Q2	$2K	Hold	7	–	–	﹤0.01%	6310
2020 Q1	$1K	Hold	7	–	–	﹤0.01%	6493
2019 Q4	$1K	Buy	+7	New	+$999	﹤0.01%	6687
2019 Q3	–	Sell	-4	Closed	-$1K	–	7120
2019 Q2	$1K	Hold	4	–	–	﹤0.01%	6746
2019 Q1	$2K	Hold	4	–	–	﹤0.01%	6544
2018 Q4	$1K	Hold	4	–	–	﹤0.01%	6614
2018 Q3	$2K	Hold	4	–	–	﹤0.01%	6538
2018 Q2	$3K	Hold	4	–	–	﹤0.01%	6185
2018 Q1	$3K	Hold	4	–	–	﹤0.01%	6062
2017 Q4	$3K	Hold	4	–	–	﹤0.01%	6212
2017 Q3	$3K	Hold	4	–	–	﹤0.01%	6523
2017 Q2	$4K	Hold	4	–	–	﹤0.01%	6127
2017 Q1	$4K	Hold	4	–	–	﹤0.01%	6293
2016 Q4	$4K	Sell	4 -1	-20%	-$1.03K	﹤0.01%	6363
2016 Q3	$11K	Hold	5	–	–	﹤0.01%	5754
2016 Q2	$9K	Hold	5	–	–	﹤0.01%	5791
2016 Q1	$9K	Sell	5 -3	-38%	-$4.78K	﹤0.01%	5773
2015 Q4	$14K	Sell	8 -4	-33%	-$7.08K	﹤0.01%	5856
2015 Q3	$21K	Hold	12	–	–	﹤0.01%	5560
2015 Q2	$33K	Hold	12	–	–	﹤0.01%	5443
2015 Q1	$35K	Hold	12	–	–	﹤0.01%	5123
2014 Q4	$32K	Sell	12 -3	-20%	-$7.76K	﹤0.01%	5227
2014 Q3	$41K	Sell	15 -98	-87%	-$318K	﹤0.01%	5037
2014 Q2	$392K	Sell	113 -90	-44%	-$320K	﹤0.01%	3647
2014 Q1	$736K	Sell	203 -12	-6%	-$47.2K	﹤0.01%	3030
2013 Q4	$811K	Sell	215 -119	-36%	-$429K	﹤0.01%	3004
2013 Q3	$1.09M	Sell	334 -70	-17%	-$205K	﹤0.01%	2689
2013 Q2	$1.02M	Buy	+404	New	+$1.01M	﹤0.01%	2557

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada's TRIB Position: Q1 2026 in Review

Royal Bank of Canada sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 33 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in TRIB in Q2 2013 and held it in 31 quarters. The position peaked at $1.09M in Q3 2013. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

Royal Bank of Canada reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
Royal Bank of Canada sold 33 Trinity Biotech shares in Q1 2026, an estimated $1K.
Royal Bank of Canada first reported a position in Trinity Biotech in Q2 2013 and held it in 31 quarters.
Royal Bank of Canada's Trinity Biotech position peaked at $1.09M in Q3 2013.
21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.